Last 12 months
Inside the activity.
0 purchase rows · 10 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2021 Filed Jul 19, 2021 20:39 UTC |
ABERCROMBIE GEORGE BDirector
|
Exercise / conversionCommon Stock | 5,000 | $2.63 | $13,150.00 |
DisclosureSEC source: 0001127602-21-022226 · form4.xml · nonDerivative · entry 1 ABERCROMBIE GEORGE B · CIK 0001485939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:29 UTC |
Hutson Nancy JDirector
|
Exercise / conversionAutomatic Stock Option Grant · Derivative | 15,000 | $0.00 Strike: $3.32 | $0.00 |
DisclosureSEC source: 0001127602-21-019792 · form4.xml · derivative · entry 5 Hutson Nancy J · CIK 0001379222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2022-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:29 UTC |
Hutson Nancy JDirector
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 8,333 | $0.00 Strike: $2.85 | $0.00 |
DisclosureSEC source: 0001127602-21-019792 · form4.xml · derivative · entry 4 Hutson Nancy J · CIK 0001379222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,333 shares Expires 2022-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:29 UTC |
Hutson Nancy JDirector
|
SaleCommon Stock | 23,333 | $16.86 | $393,394.38 |
DisclosureSEC source: 0001127602-21-019792 · form4.xml · nonDerivative · entry 3 Hutson Nancy J · CIK 0001379222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,073 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021. F2 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $16.76 to $17.00. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:29 UTC |
Hutson Nancy JDirector
|
Exercise / conversionCommon Stock | 15,000 | $3.32 | $49,800.00 |
DisclosureSEC source: 0001127602-21-019792 · form4.xml · nonDerivative · entry 2 Hutson Nancy J · CIK 0001379222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,406 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:29 UTC |
Hutson Nancy JDirector
|
Exercise / conversionCommon Stock | 8,333 | $2.85 | $23,749.05 |
DisclosureSEC source: 0001127602-21-019792 · form4.xml · nonDerivative · entry 1 Hutson Nancy J · CIK 0001379222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,406 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 20:33 UTC |
Sheridan William PChief Medical Officer
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 5,901 | $0.00 Strike: $5.45 | $0.00 |
DisclosureSEC source: 0001127602-21-018509 · form4.xml · derivative · entry 14 Sheridan William P · CIK 0001439174 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,901 shares Expires 2023-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2020. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 20:33 UTC |
Sheridan William PChief Medical Officer
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 64,299 | $0.00 Strike: $5.59 | $0.00 |
DisclosureSEC source: 0001127602-21-018509 · form4.xml · derivative · entry 13 Sheridan William P · CIK 0001439174 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 64,299 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2020. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 20:33 UTC |
Sheridan William PChief Medical Officer
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 21,614 | $0.00 Strike: $4.73 | $0.00 |
DisclosureSEC source: 0001127602-21-018509 · form4.xml · derivative · entry 12 Sheridan William P · CIK 0001439174 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,614 shares Expires 2022-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2020. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 20:33 UTC |
Sheridan William PChief Medical Officer
|
SaleCommon Stock | 91,814 | $15.02 | $1,379,046.28 |
DisclosureSEC source: 0001127602-21-018509 · form4.xml · nonDerivative · entry 8 Sheridan William P · CIK 0001439174 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,475 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2020. F3 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $15.00 to $15.10. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 20:33 UTC |
Sheridan William PChief Medical Officer
|
Exercise / conversionCommon Stock | 5,901 | $5.45 | $32,160.45 |
DisclosureSEC source: 0001127602-21-018509 · form4.xml · nonDerivative · entry 7 Sheridan William P · CIK 0001439174 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,289 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2020. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 20:33 UTC |
Sheridan William PChief Medical Officer
|
Exercise / conversionCommon Stock | 64,299 | $5.59 | $359,431.41 |
DisclosureSEC source: 0001127602-21-018509 · form4.xml · nonDerivative · entry 6 Sheridan William P · CIK 0001439174 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,388 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2020. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 20:33 UTC |
Sheridan William PChief Medical Officer
|
Exercise / conversionCommon Stock | 21,614 | $4.73 | $102,234.22 |
DisclosureSEC source: 0001127602-21-018509 · form4.xml · nonDerivative · entry 5 Sheridan William P · CIK 0001439174 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2020. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 20:27 UTC |
INGRAM ROBERT ALEXANDERDirector
|
GrantCommon Stock | 1,188 | $15.77 | $18,734.76 |
DisclosureSEC source: 0001127602-21-018501 · form4.xml · nonDerivative · entry 1 INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,201 F1 · security: Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $18,750. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 20:24 UTC |
Hutson Nancy JDirector
|
GrantCommon Stock | 317 | $15.77 | $4,999.09 |
DisclosureSEC source: 0001127602-21-018492 · form4.xml · nonDerivative · entry 1 Hutson Nancy J · CIK 0001379222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,073 F1 · security: Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $10,000. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 20:18 UTC |
HEGGIE THERESADirector
|
GrantCommon Stock | 317 | $15.77 | $4,999.09 |
DisclosureSEC source: 0001127602-21-018474 · form4.xml · nonDerivative · entry 1 HEGGIE THERESA · CIK 0001760020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,166 F1 · security: Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $10,000. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 20:16 UTC |
ASELAGE STEVEDirector
|
GrantCommon Stock | 634 | $15.77 | $9,998.18 |
DisclosureSEC source: 0001127602-21-018470 · form4.xml · nonDerivative · entry 1 ASELAGE STEVE · CIK 0001221599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,130 F1 · security: Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $10,000. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 20:33 UTC |
Sheridan William PChief Medical Officer
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 11,099 | $0.00 Strike: $5.45 | $0.00 |
DisclosureSEC source: 0001127602-21-018509 · form4.xml · derivative · entry 11 Sheridan William P · CIK 0001439174 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,901 Underlying: Common Stock · 11,099 shares Expires 2023-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2020. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 20:33 UTC |
Sheridan William PChief Medical Officer
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 35,701 | $0.00 Strike: $5.59 | $0.00 |
DisclosureSEC source: 0001127602-21-018509 · form4.xml · derivative · entry 10 Sheridan William P · CIK 0001439174 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,299 Underlying: Common Stock · 35,701 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2020. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 20:33 UTC |
Sheridan William PChief Medical Officer
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 24,959 | $0.00 Strike: $4.73 | $0.00 |
DisclosureSEC source: 0001127602-21-018509 · form4.xml · derivative · entry 9 Sheridan William P · CIK 0001439174 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,614 Underlying: Common Stock · 24,959 shares Expires 2022-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2020. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 20:33 UTC |
Sheridan William PChief Medical Officer
|
SaleCommon Stock | 71,759 | $15.00 | $1,076,385.00 |
DisclosureSEC source: 0001127602-21-018509 · form4.xml · nonDerivative · entry 4 Sheridan William P · CIK 0001439174 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,475 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2020. F2 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $15.00 to $15.01. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 20:33 UTC |
Sheridan William PChief Medical Officer
|
Exercise / conversionCommon Stock | 11,099 | $5.45 | $60,489.55 |
DisclosureSEC source: 0001127602-21-018509 · form4.xml · nonDerivative · entry 3 Sheridan William P · CIK 0001439174 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2020. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 20:33 UTC |
Sheridan William PChief Medical Officer
|
Exercise / conversionCommon Stock | 35,701 | $5.59 | $199,568.59 |
DisclosureSEC source: 0001127602-21-018509 · form4.xml · nonDerivative · entry 2 Sheridan William P · CIK 0001439174 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,135 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2020. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 20:33 UTC |
Sheridan William PChief Medical Officer
|
Exercise / conversionCommon Stock | 24,959 | $4.73 | $118,056.07 |
DisclosureSEC source: 0001127602-21-018509 · form4.xml · nonDerivative · entry 1 Sheridan William P · CIK 0001439174 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,434 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2020. Read SEC document |
| May 25, 2021 Filed May 27, 2021 20:39 UTC |
LEVIN ALAN GDirector
|
GrantAutomatic Stock Option Grant · Derivative | 40,000 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0001127602-21-018189 · form4.xml · derivative · entry 1 LEVIN ALAN G · CIK 0001174452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-05-25 F1 · security: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan. Read SEC document |
| May 25, 2021 Filed May 27, 2021 20:33 UTC |
LEE KENNETH B JRDirector
|
GrantAutomatic Stock Option Grant · Derivative | 40,000 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0001127602-21-018186 · form4.xml · derivative · entry 1 LEE KENNETH B JR · CIK 0001208570 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-05-25 F1 · security: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan. Read SEC document |
| May 25, 2021 Filed May 27, 2021 20:28 UTC |
INGRAM ROBERT ALEXANDERDirector
|
GrantAutomatic Stock Option Grant · Derivative | 40,000 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0001127602-21-018181 · form4.xml · derivative · entry 1 INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-05-25 F1 · security: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan. Read SEC document |
| May 25, 2021 Filed May 27, 2021 20:24 UTC |
Hutson Nancy JDirector
|
GrantAutomatic Stock Option Grant · Derivative | 40,000 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0001127602-21-018179 · form4.xml · derivative · entry 1 Hutson Nancy J · CIK 0001379222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-05-25 F1 · security: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan. Read SEC document |
| May 25, 2021 Filed May 27, 2021 20:21 UTC |
HEGGIE THERESADirector
|
GrantAutomatic Stock Option Grant · Derivative | 40,000 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0001127602-21-018177 · form4.xml · derivative · entry 1 HEGGIE THERESA · CIK 0001760020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-05-25 F1 · security: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan. Read SEC document |
| May 25, 2021 Filed May 27, 2021 20:16 UTC |
ASELAGE STEVEDirector
|
GrantAutomatic Stock Option Grant · Derivative | 40,000 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0001127602-21-018174 · form4.xml · derivative · entry 1 ASELAGE STEVE · CIK 0001221599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-05-25 F1 · security: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan. Read SEC document |
| May 25, 2021 Filed May 27, 2021 20:11 UTC |
ABERCROMBIE GEORGE BDirector
|
GrantAutomatic Stock Option Grant · Derivative | 40,000 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0001127602-21-018171 · form4.xml · derivative · entry 1 ABERCROMBIE GEORGE B · CIK 0001485939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-05-25 F1 · security: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan. Read SEC document |
| May 24, 2021 Filed May 26, 2021 20:12 UTC |
ABERCROMBIE GEORGE BDirector
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 6,667 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0001127602-21-018061 · form4.xml · derivative · entry 3 ABERCROMBIE GEORGE B · CIK 0001485939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 6,667 shares Expires 2021-10-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021. F3 · derivative.exercise_date: The option vested 1/8 per month for a period of 8 months, beginning on October 10, 2011. Read SEC document |
| May 24, 2021 Filed May 26, 2021 20:12 UTC |
ABERCROMBIE GEORGE BDirector
|
SaleCommon Stock | 6,667 | $13.90 | $92,671.30 |
DisclosureSEC source: 0001127602-21-018061 · form4.xml · nonDerivative · entry 2 ABERCROMBIE GEORGE B · CIK 0001485939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021. F2 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $13.77 to $14.11. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| May 24, 2021 Filed May 26, 2021 20:12 UTC |
ABERCROMBIE GEORGE BDirector
|
Exercise / conversionCommon Stock | 6,667 | $2.63 | $17,534.21 |
DisclosureSEC source: 0001127602-21-018061 · form4.xml · nonDerivative · entry 1 ABERCROMBIE GEORGE B · CIK 0001485939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021. Read SEC document |
| May 12, 2021 Filed May 13, 2021 20:43 UTC |
Barnes Alane PChief Legal Officer
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 35,852 | $0.00 Strike: $4.73 | $0.00 |
DisclosureSEC source: 0001127602-21-016587 · form4.xml · derivative · entry 9 Barnes Alane P · CIK 0001584348 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,852 shares Expires 2022-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The reporting person engaged in a non-market exercise and hold transaction with respect to these stock options and the underlying shares. Read SEC document |
| May 12, 2021 Filed May 13, 2021 20:43 UTC |
Barnes Alane PChief Legal Officer
|
Exercise / conversionCommon Stock | 35,852 | $4.73 | $169,579.96 |
DisclosureSEC source: 0001127602-21-016587 · form4.xml · nonDerivative · entry 5 Barnes Alane P · CIK 0001584348 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,127 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The reporting person engaged in a non-market exercise and hold transaction with respect to these stock options and the underlying shares. Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:43 UTC |
Barnes Alane PChief Legal Officer
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 68,000 | $0.00 Strike: $5.45 | $0.00 |
DisclosureSEC source: 0001127602-21-016587 · form4.xml · derivative · entry 8 Barnes Alane P · CIK 0001584348 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 68,000 shares Expires 2023-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested upon the achievement of performance-based vesting criteria with respect to 17,000 shares on each of May 26, 2014, December 19, 2014, May 13, 2015 and December 3, 2020. Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:43 UTC |
Barnes Alane PChief Legal Officer
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 33,132 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0001127602-21-016587 · form4.xml · derivative · entry 7 Barnes Alane P · CIK 0001584348 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,132 shares Expires 2023-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:43 UTC |
Barnes Alane PChief Legal Officer
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 1,648 | $0.00 Strike: $4.73 | $0.00 |
DisclosureSEC source: 0001127602-21-016587 · form4.xml · derivative · entry 6 Barnes Alane P · CIK 0001584348 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,852 Underlying: Common Stock · 1,648 shares Expires 2022-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:43 UTC |
Barnes Alane PChief Legal Officer
|
SaleCommon Stock | 102,780 | $12.04 | $1,237,471.20 |
DisclosureSEC source: 0001127602-21-016587 · form4.xml · nonDerivative · entry 4 Barnes Alane P · CIK 0001584348 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,275 F1 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $12.00 to $12.15. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:43 UTC |
Barnes Alane PChief Legal Officer
|
Exercise / conversionCommon Stock | 68,000 | $5.45 | $370,600.00 |
DisclosureSEC source: 0001127602-21-016587 · form4.xml · nonDerivative · entry 3 Barnes Alane P · CIK 0001584348 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:43 UTC |
Barnes Alane PChief Legal Officer
|
Exercise / conversionCommon Stock | 33,132 | $1.42 | $47,047.44 |
DisclosureSEC source: 0001127602-21-016587 · form4.xml · nonDerivative · entry 2 Barnes Alane P · CIK 0001584348 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:43 UTC |
Barnes Alane PChief Legal Officer
|
Exercise / conversionCommon Stock | 1,648 | $4.73 | $7,795.04 |
DisclosureSEC source: 0001127602-21-016587 · form4.xml · nonDerivative · entry 1 Barnes Alane P · CIK 0001584348 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:02 UTC |
ABERCROMBIE GEORGE BDirector
|
SaleCommon Stock | 7,000 | $12.70 | $88,900.00 |
DisclosureSEC source: 0001127602-21-016433 · form4.xml · nonDerivative · entry 1 ABERCROMBIE GEORGE B · CIK 0001485939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 F1 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $12.69 to $12.72. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:26 UTC |
Thackray Helen M.Director · Chief R&D Officer
|
GrantEmp. Stock Option (Right to Buy) · Derivative | 400,000 | $0.00 Strike: $10.17 | $0.00 |
DisclosureSEC source: 0001127602-21-012780 · form4.xml · derivative · entry 2 Thackray Helen M. · CIK 0001589725 · Director · Chief R&D Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2031-03-31 F2 · shares: Options become exercisable at a rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:26 UTC |
Thackray Helen M.Director · Chief R&D Officer
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-012780 · form4.xml · nonDerivative · entry 1 Thackray Helen M. · CIK 0001589725 · Director · Chief R&D Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 F1 · shares: Award of Restricted Stock Units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant. Read SEC document |
| March 18, 2021 Filed Mar 22, 2021 20:19 UTC |
Jones Michael LExec. Director, Finance - PAO
|
Exercise / conversionEmp. Stock Option (Right to Buy) · Derivative | 4,500 | $0.00 Strike: $3.51 | $0.00 |
DisclosureSEC source: 0001127602-21-011668 · form4.xml · derivative · entry 2 Jones Michael L · CIK 0001800060 · Exec. Director, Finance - PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,500 shares Expires 2021-03-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 18, 2021 Filed Mar 22, 2021 20:19 UTC |
Jones Michael LExec. Director, Finance - PAO
|
Exercise / conversionCommon Stock | 4,500 | $3.51 | $15,795.00 |
DisclosureSEC source: 0001127602-21-011668 · form4.xml · nonDerivative · entry 1 Jones Michael L · CIK 0001800060 · Exec. Director, Finance - PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,348 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:50 UTC |
HEGGIE THERESADirector
|
GrantCommon Stock | 463 | $10.78 | $4,991.14 |
DisclosureSEC source: 0001127602-21-008754 · form4.xml · nonDerivative · entry 1 HEGGIE THERESA · CIK 0001760020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,849 F1 · security: Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $10,000. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:55 UTC |
INGRAM ROBERT ALEXANDERDirector
|
GrantCommon Stock | 1,739 | $10.78 | $18,746.42 |
DisclosureSEC source: 0001127602-21-008766 · form4.xml · nonDerivative · entry 1 INGRAM ROBERT ALEXANDER · CIK 0001219890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,013 F1 · security: Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $18,750. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.